help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehmann, N.
Right arrow Articles by Fahmy, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehmann, N.
Right arrow Articles by Fahmy, K.

Biophys J, February 2002, p. 793-802, Vol. 82, No. 2

Suramin Affects Coupling of Rhodopsin to Transducin

Nicole Lehmann,* Gopala Krishna Aradhyam,dagger and Karim Fahmy*

 *Institut für Molekulare Medizin und Zellforschung, Albert-Ludwigs-Universität, D-79104 Freiburg, Germany; and  dagger Howard Hughes Medical Institute, Laboratory of Molecular Biology and Biochemistry, Rockefeller University, New York, New York 10021 USA


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

Suramin, a polysulfonated naphthylurea, is under investigation for the treatment of several cancers. It interferes with signal transduction through Gs, Gi, and Go, but structural and kinetic aspects of the molecular mechanism are not well understood. Here, we have investigated the influence of suramin on coupling of bovine rhodopsin to Gt, where G-protein activation and receptor structure can be monitored by spectroscopic in vitro assays. Gt fluorescence changes in response to rhodopsin-catalyzed nucleotide exchange reveal that suramin inhibits Gt activation by slowing down the rate of complex formation between metarhodopsin-II and Gt. The metarhodopsin-I/-II photoproduct equilibrium, GTPase activity, and nucleotide uptake by Gt are unaffected. Attenuated total reflection Fourier transform infrared spectroscopy shows that the structure of rhodopsin, metarhodopsin-II, and the metarhodopsin-II Gt complex is also not altered. Instead, suramin dissociates Gt from disk membranes in the dark, whereas metarhodopsin-II Gt complexes are stable. Förster resonance energy transfer suggests a suramin-binding site near Trp207 on the Gtalpha subunit (Kd ~0.5 µM). The kinetic analyses and the structural data are consistent with a specific perturbation by suramin of the membrane attachment site on Gtalpha . Disruption of membrane anchoring may contribute to some of the effects of suramin exerted on other G-proteins.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

Suramin, a hexasulfonated polyaromatic naphthylurea (1.4 kDa), is under study for therapeutic activity in phase II trials in the treatment of several cancers (Mirza et al., 1997; Dawson et al., 1998; Dreicer et al., 1999). It exhibits antiangiogenetic and antiproliferative activity (Firsching et al., 1995) by interfering with the binding of several growth factors to their receptors (Coffey et al., 1987). These properties can be enhanced in suramin analogs (Gagliardi et al., 1998). However, adverse effects of suramin are dose-limiting (Chaudhry et al., 1996), and the molecular basis of its action is not well understood. The function of several cellular signaling proteins, such as protein-tyrosine phosphatases (Zhang et al., 1998) and protein kinase C (Khaled et al., 1995) is perturbed, and recent interest in suramin focuses on its ability to interfere also with signaling through G-protein-coupled receptors (GPCRs). GPCRs are heptahelical transmembrane proteins that respond to extracellular signals, such as binding of a hormone or a neurotransmitter, by catalyzing GDP/GTP exchange in cytosolic guanosine-nucleotide-binding proteins (G-proteins) (for reviews see Ji et al., 1998; Gether, 2000). Suramin has been shown to uncouple alpha 2- and beta 2-adrenergic receptors from Gi and Gs, respectively (Huang et al., 1990). It has also been shown that suramin inhibits activation of pertussis-toxin-sensitive G-proteins by delta -opioid receptors in NG 108-15 cell membranes, whereas nucleotide exchange induced by serum factors binding to an unidentified receptor was not affected (Butler et al., 1988). Based on these initial observations, the potential of suramin analogs to interfere with signaling by different receptor G-protein tandems has been investigated systematically. A suramin analog has been described that uncouples A1 adenosine and D2 dopamine receptors from Gi/Go with different specificity (Beindl et al., 1996; Waldhoer et al., 1998), and a number of analogs have been synthesized that act as subtype-specific G-protein inhibitors (Hohenegger et al., 1998; Waldhoer et al., 1998). Such studies emphasize the role of G-proteins as potential drug targets (Höller et al., 1999). However, details of the molecular mechanism by which suramin affects structural and kinetic parameters of receptor G-protein interactions remain to be elucidated. In an attempt to exploit a well characterized in vitro model system for GPCR signaling, we have investigated the effect of suramin on activation of transducin (Gt) by the bovine photoreceptor rhodopsin. For this system, biophysical assays for conformational changes of the receptor, Gt binding, and Gt activation are available. Based on the homology of class I (rhodopsin-like) GPCRs, a study of the action of suramin on rhodopsin Gt interactions helps to identify molecular mechanisms by which the drug may affect signaling in related systems.

Rhodopsin is a prototypical GPCR (Helmreich and Hofmann, 1996; Menon et al., 2001; Okada et al., 2001) and the only one for which a crystal structure has been solved (Palczewski et al., 2000). Rhodopsin is unique as it is not ligand-activated. Instead, 11-cis-retinal is covalently attached to Lys296 of the apoprotein via a protonated Schiff base (Oseroff and Callender, 1974). Photoisomerization to all-trans-retinal promotes structural changes involving helix-helix interactions and rigid body movements (Farrens et al., 1996; Han et al., 1996; Sheikh et al., 1996). As a consequence, cytosolic domains of the active metarhodopsin-II (MII) state bind Gt and catalyze GDP/GTP exchange. Signaling by the rhodopsin Gt tandem has been optimized for maximal light sensitivity, which implies minimization of dark noise (Birge and Barlow, 1995; Rieke and Baylor, 1996). Correspondingly, basal nucleotide exchange, typical of other G-proteins, is negligible in Gt. The unique features of rhodopsin and Gt suggest that interference with receptor coupling is the predominant mode of action by which a pharmacologically active substance may modulate Gt activation. Other potential perturbations such as interference with basal G-protein activation or competition with agonist binding are not expected to contribute to the readout from this model system.

We have applied fluorescence spectroscopy to analyze binding of suramin to Gtalpha and to monitor rhodopsin-catalyzed Gt activation. By attenuated total reflection (ATR) Fourier transform infrared (FTIR) spectroscopy we have investigated the influence of suramin on the structure of rhodopsin and the MIIGt complex. We show that suramin binds to Gtalpha but does not affect either GTP uptake or GTPase activity. Likewise, structural changes during rhodopsin activation are not influenced. Instead, the rate of MIIGt formation is reduced by a dose-dependent inhibition of membrane anchoring of Gt. In addition to inferences on receptor G-protein coupling in nonvisual signaling, the data are relevant for the molecular characterization of side effects on vision in patients receiving suramin treatment. A variety of ocular symptoms have been described (for example, Hemady et al., 1996).


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

Purification of rhodopsin and transducin

Preparation of washed membranes from bovine rod outer segments (ROSs) was carried out as described (Papermaster, 1982) with minor modifications. Gt was purified from illuminated, osmotically shocked ROSs by successive washes and hexyl agarose chromatography (Kühn, 1980; Fung et al., 1981). Gt was eluted with 300 mM NaCl in buffer solution (10 mM sodium phosphate, pH 7.2, 2 mM MgCl2, 1 mM dithiothreitol (DTT), 0.1 mM phenylmethylsulfonyl fluoride). Pooled fractions were diluted with buffer to a final concentration of 100 mM NaCl. Gtbeta gamma and Gtalpha were isolated from Gt (prepared from bovine retinas, Lawson, Lincoln, NE) according to published methods (Shichi et al., 1984) using a Hitachi LC-organizer high-performance liquid chromatography system with 1 ml of Hi-Trap Blue Sepharose column (Amersham Pharmacia Biotech, Piscataway, NJ). The proteins were eluted with a 0-2 M NaCl gradient. Protein concentrations were determined using the Bio-Rad protein assay reagent according to manufacturer's instructions. The subunits were stored at -20°C in a 50% glycerol buffer until use.

ATR-FTIR spectroscopy

Disk membranes (1-2 nmol of rhodopsin) were dried under nitrogen on a trapezoidal (45°) internal reflection element (IRE) made of ZnSe (3.5 cm2) mounted in a Bruker A737 temperature-controlled dialysis-coupled (10,000 MW cutoff) ATR cell. Under these conditions, membrane stacks of at least 50 layers are expected to form, when the surface coverage by rhodopsin in disk membranes is estimated from the crystal structure (Palczewski et al., 2000) to be ~1500 Å2. Thus, more than 98% of rhodopsin is excluded from possible denaturing influences of the ZnSe surface and the functionality (normal light-dependent MII formation and Gt activation) of the resulting matrix of immobilized disk membranes has been demonstrated (Fahmy, 1998).

After addition of Gt (0.5-1 ml, 4-6 µM, 10 mM sodium phosphate buffer, pH 7.2, 100 mM NaCl, 2 mM MgCl2, 1 mM DTT) to the sample compartment, its association with disk membranes was monitored in a vector 22 FTIR spectrophotometer (Bruker, Karlsruhe, Germany). GTP, suramin, and heparin were purchased from Sigma-Aldrich (Milwaukee, WI) and used without further purification. Dissociation of Gt from disk membranes was induced by addition of the appropriate amounts of these substances to the dialysis reservoir of the ATR cell. Subsequent spectral changes were measured as the difference between the absorption (calculated from 256 interferograms) at a given time after and the absorption immediately before the addition of either substance. Experiments were carried out at 17°C. Light-induced IR absorption changes during metarhodopsin II (MII) formation in the absence of Gt were measured at 10°C (10 mM sodium phosphate buffer, pH 5, 100 mM NaCl, 30 s illumination with 150-W projector light using a GG 495 filter from Schott, (Mainz, Germany).

Fluorescence measurements

GTP-induced changes of tryptophan fluorescence from Gt were recorded with a home-built instrument, using fiber optics attached to a temperature-controlled cuvette holder for excitation and emission in 90° geometry. Excitation was achieved with UV light from a deuterium lamp equipped with an interference filter transmitting 290-310-nm light (300FS10-25, L.O.T. Oriel, Darmstadt, Germany). Emitted light (lambda max = 345 nm) was detected by a photomultiplier after transmission through a 335-nm cutoff filter (WG 335 Schott). Integration time of the fluorescence signals was 4 s and the reaction mixture was continuously stirred by a magnetic stir bar in a quartz cuvette. A suspension of disk membranes in buffer containing 1-2 µM Gt was photoactivated 5 min before starting fluorescence recordings. The reaction mixture (0.8 ml) was thermostatted to 27°C.

FRET from suramin to Gtalpha was measured in a Spex Fluorolog 3-11 tau 3 spectrofluorometer equipped with a 450-W xenon arc lamp. Excitation was at 295 nm, and emission was recorded between 315 and 450 nm. The fluorescence spectra were recorded in 10 mM Tris buffer (pH 7.2), 100 mM NaCl, 2 mM MgCl2, 1 mM DTT, 5 µM GDP, and 0.01% dodecyl maltoside.

Data analysis

Kinetic fluorescence data were fitted by numerical integration of rate equations using the Newton method. In a two-step reaction model, the time derivative of the concentration of the GTP-bound state of Gt was assumed to depend on the rate constants k1 and k2, describing formation of Gtalpha (GTP) from Gtalpha (GDP) and GTP (catalyzed by MII) and decay of Gtalpha (GTP) to Gtalpha (GDP) and Pi by intrinsic GTPase activity of Gtalpha , respectively:
<IT>d</IT>[<UP>G<SUB>t&agr;</SUB></UP>(<UP>GTP</UP>)]<UP>/</UP><IT>dt</IT>=<IT>k</IT><SUB><UP>1</UP></SUB>×[<UP>G<SUB>t&agr;</SUB></UP>(<UP>GDP</UP>)]×[<UP>GTP</UP>] (1)

<UP>−</UP><IT>k</IT><SUB><UP>2</UP></SUB><UP>×</UP>[<UP>G<SUB>t&agr;</SUB></UP>(<UP>GTP</UP>)]
Microscopic rate constants for the formation of MIIGt as well as for GDP release were not explicitly included. Instead, the concentration of MIIGt was implicitly defined in proportion to the concentration of Gtalpha (GDP).

In a more realistic three-step model, the formation of the MIIGt complex from MII and Gt(GDP) and uptake of GTP (followed by immediate dissociation of the MIIGt complex) was described by the rate constants kc and ku, respectively:
d[<UP>MIIG<SUB>t</SUB></UP>]<UP>/</UP><IT>dt</IT>=<IT>k</IT><SUB><UP>c</UP></SUB>×[<UP>MII</UP>]×[<UP>G<SUB>t&agr;</SUB></UP>(<UP>GDP</UP>)] (2)

<UP>−</UP><IT>k</IT><SUB><UP>u</UP></SUB><UP> × </UP>[<UP>MIIG<SUB>t</SUB></UP>]×[<UP>GTP</UP>]

<IT>d</IT>[<UP>G<SUB>t&agr;</SUB></UP>(<UP>GTP</UP>)]<UP>/</UP><IT>dt</IT>=<IT>k</IT><SUB><UP>u</UP></SUB><UP> × </UP>[<UP>MIIG<SUB>t</SUB></UP>]<UP> × </UP>[<UP>GTP</UP>] (3)

<UP>−</UP><IT>k</IT><SUB><UP>h</UP></SUB><UP> × </UP>[<UP>G<SUB>t&agr;</SUB></UP>(<UP>GTP</UP>)]<UP>,</UP>
where kh is the rate constant for GTP hydrolysis. In contrast to the two-step model, the rate of MIIGt formation, rather than its concentration, is proportional to the concentration of Gtalpha (GDP) in the three-step model. This leads to a superior simulation when MIIGt formation becomes rate limiting.

Data on FRET from Gtalpha to suramin were analyzed to determine the fraction f(Gtalpha ) of free Gtalpha in the presence of varying amounts of suramin according to Eq. 4:
<IT>f</IT>(<UP>G<SUB>t&agr;</SUB></UP>)<UP> = </UP>(<IT>F</IT><SUB><UP>S</UP></SUB><UP> − </UP><IT>F</IT><SUB><UP>q</UP></SUB>)<UP>/</UP>(<IT>F</IT><SUB><UP>0</UP></SUB><UP> − </UP><IT>F</IT><SUB><UP>q</UP></SUB>)<UP>,</UP> (4)
where Fs, Fq, and F0 is the tryptophan fluorescence in the presence of a given suramin concentration, at maximal concentration of suramin, and in the absence of suramin, respectively. The right side of Eq. 4 was determined from peak emission values at 343 nm. These were corrected for inner filtering by suramin absorption at the excitation and emission wavelength as described (Pigault and Gérard, 1984) using absorption coefficients of 20,500 and 9,440 M-1 cm-1 at 295 and 343 nm, respectively. Absorption and fluorescence spectra of suramin have been published (Mély et al., 1997; Zhang et al., 1998).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

Fluorescence monitoring of Gt activation

To investigate the action of suramin on receptor-dependent G-protein signaling, we have designed experiments using the bovine photoreceptor rhodopsin and Gt as a model system. Rhodopsin-catalyzed nucleotide exchange and GTP hydrolysis by Gt were monitored with a real-time Gt activation assay (Fahmy and Sakmar, 1993; Ernst et al., 2000) based on intrinsic G-protein fluorescence (Higashijima et al., 1987). The fluorescence increases of Trp207 of Gtalpha (GTP) or Gtalpha (GTPgamma S) versus Gtalpha (GDP) (Faurobert et al., 1993) allow the observation of nucleotide uptake and hydrolysis during multiple cycles of Gt activation. Fig. 1 shows fluorescence recordings from Gt in a suspension of light-activated disk membranes. Repeated addition of GTP caused transient fluorescence increases corresponding to the increase of [Gtalpha (GTP)] followed by a decrease due to GTPase activity of Gtalpha . The traces evidence the catalytical nature of the Gt turnover and the stability of rhodopsin Gt interactions during the time of the experiment. Addition of a saturating amount of the nonhydrolyzable GTP analog GTPgamma S caused a persistent fluorescence increase. The decrease in fluorescence upon further addition of GTPgamma S as well as the fluorescence signal reached at the end of GTP-induced signals scaled precisely with the corresponding dilution of the reaction buffer.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 1   Influence of suramin on nucleotide-dependent fluorescence changes of Gtalpha ([GTP] < [Gt]). Arrows indicate injection of GTP (1.4 µM) and GTPgamma S (6 µM) to a reaction mixture (10 mM sodium phosphate, pH 7.2, 100 mM NaCl, 2 mM MgCl2, 1 mM DTT) containing photoactivated rhodopsin (150 nM) in suspension of disk membranes and freshly prepared Gt (1.8 µM). Experiments were carried out at 27°C. Bars delimit identical areas under each trace when normalized to the size of the respective GTPgamma S-induced fluorescence increase. (A) Fluorescence signals in the absence of suramin. The curve drawn through the first GTP-induced signal was calculated according to Eq. 1 with k1 = 0.147 µM-1s-1 and k2 = 0.059 s-1. For the simulation of the GTPgamma S-induced signal, k2 was set to zero. (B) Fluorescence signals at 3 µM suramin (initial fluorescence 90% of that in A). (C) Fluorescence signals at 12 µM suramin (initial fluorescence 67% of that in A). The first GTP-induced signal has been fitted according to Eq. 1 with k1 = 0.100 s-1 and k2 = 0.058 s-1. The same transient as well as the GTPgamma S-induced signal was replotted to the right in a scale in which the GTPgamma S-induced signal is normalized to that in A, to better appreciate the normalized peak area of the GTP-induced signal (see text for details). (D) Fluorescence signals at 24 µM suramin (initial fluorescence 50% of that in A). The curve drawn through the GTPgamma S-induced signal was calculated as in A, but k1 was reduced by a factor of 0.14 (k2 = 0.0 s-1).

The described assay allows an accurate evaluation of the kinetics of rhodopsin Gt coupling. The peak height and width of the GTP-induced transients is determined by the apparent rate of the rising and falling phase of [Gtalpha (GTP)]. The peak height (normalized to the GTPgamma S-induced signal) decreased whereas the peak width increased as a function of suramin concentration. This indicates that suramin caused an increase of the apparent fluorescence rise time. In principle, the effect of suramin may be accounted for by denaturing Gt or rhodopsin. However, the more thorough quantitative analysis of reaction kinetics as well as spectroscopic data, presented below, strongly suggest that the data in Fig. 1 must be explained by a specific inhibitory effect of suramin on the MII-dependent formation of Gtalpha (GTP).

For a given rate of GTP hydrolysis, the area under the transient fluorescence signal is a measure of the amount of GTP hydrolyzed. Because identical aliquots of GTP were injected in all experiments, the peak area is not expected to depend on the presence of suramin if the drug exclusively influenced the formation of MIIGt. Integration intervals and baseline positions for GTP-induced peaks are represented by the length and vertical position, respectively, of the bars in Fig. 1. In trace A, the baseline was determined by the fluorescence level at the end of the transient. In traces B-D, baselines were adjusted to obtain identical normalized peak areas as in trace A. The correspondence of normalized areas under GTP-induced signals is exemplified in panel C, where the GTP-induced transient has been replotted in a scale in which the GTPgamma S-induced signal (shown to the right) matches that in A. Evidently, the criterion of invariant peak areas yields excellent agreement with the measured traces. Thus, an effect of suramin on GTPase activity is negligible within the accuracy of the experiment.

Estimates of the apparent rate constants k1 and k2 for GTP uptake and hydrolysis, respectively, can be obtained in the realm of a two-step reaction model described by Eq. 1. The larger k1/k2, the higher is the fluorescence peak. For each peak, k1/k2 assumes well defined values that were used to generate the curves drawn through the data in Fig. 1. All fluorescence traces are well described by the two-step model. The influence of suramin can be accounted for by a successive reduction of k1 at a constant value of k2. This agrees with the model-independent evaluation of peak areas. At all suramin concentrations tested, the data could be fitted with hydrolysis rates of 0.044 s-1 < k2 < 0.059 s-1, which is in agreement with the range of reported hydrolysis rates (Yamanaka et al., 1985; Antonny et al., 1993; Otto-Bruc et al., 1994) and renders unlikely denaturation of Gt by suramin. In contrast, k1 had to be reduced by factors of 0.85, 0.52, 0.38, and 0.14 in the presence of 3, 6, 12, and 24 µM suramin, respectively, relative to its value in the absence of suramin. Therefore, a pronounced influence is exerted on the reaction(s) that lead to uptake of GTP by Gt, whereas an effect of suramin on GTP hydrolysis (k2) must be small, if it is present at all. The drop in k1 for Gt activation with GTPgamma S (k2 = 0) parallels that for activation with GTP. For example, the GTPgamma S-induced signal at 24 µM suramin (Fig. 1 D) is approximated by the model when k1 is reduced by the same factor (0.14) that was used for the simulation of the GTP-induced signal.

In the measurements shown in Fig. 1, where [GTP] < [Gt], the reaction mixture had become depleted of GTP before a steady state was reached during which GTP hydrolysis can approximately balance the formation of Gtalpha (GTP). At higher [GTP], a nearly constant fraction of Gtalpha (GTP) was present before the pool of nucleotide was eventually turned over. This resulted in a broadening of the fluorescence signal that cannot be reproduced by the two-step reaction model. Fluorescence time courses with [GTP] > [Gt] (Fig. 2) were analyzed in a more realistic model (Eqs. 2 and 3) to assess specifically the influence of suramin on MIIGt formation (kc) and GTP uptake (ku). The values for ku and kh in the absence of suramin were held constant and only kc was varied. In an iterative process, a pair of rate constants ku and kh was found that allowed simultaneous fits of reasonable quality to all traces. At constant rates of ku of 0.14 µM-1 s-1 and kh of 0.031 s-1, kc was reduced by factors of 0.43, 0.3, and 0.12 at 2.5, 5.0, and 10.0 µM suramin, respectively, relative to its value of 0.7 µM-1 s-1 in the absence of suramin. [GTP] was increased by 18% at 10 µM suramin (Fig. 2 D) to extend the steady state during which [Gtalpha (GTP)] was only slowly changing. In contrast to the two-step model, the three-step model is clearly able to describe this situation. The rate constants for MIIGt association and GTP hydrolysis in the absence of suramin are of the correct magnitude (Schleicher and Hofmann, 1987; Yamanaka et al., 1985; Antonny et al., 1993; Otto-Bruc et al., 1994), and we conclude that suramin acts primarily on kc. The additional curves in Fig. 2, C and D (thin lines) were obtained by exclusively adjusting ku. Obviously, the shape of the resulting time courses is incorrectly described, particularly at high suramin concentrations. This supports a specific action of suramin on MIIGt formation while other molecular processes on the Gt activation/deactivation pathway can proceed normally. In control experiments (Fig. 2, E-G) in which heparin was substituted for suramin, the fluorescence changes were not affected, ruling out a general polyanionic effect on Gt activation. In summary, the kinetic analyses reveal that suramin slows down the light-dependent activation of Gt by reducing the rate of MIIGt complex formation, whereas GTP uptake and GTP hydrolysis is not affected.



View larger version (23K):
[in this window]
[in a new window]
 
FIGURE 2   Influence of suramin on nucleotide-dependent fluorescence changes of Gtalpha ([GTP] > [Gt]). Injection of GTP (2.5 µM (A-C), 3.1 µM (D)) to a reaction mixture containing photoactivated rhodopsin (130 nM) in suspension of disk membranes and freshly prepared Gt (1 µM). Experimental conditions are as given in Fig. 1. The scale bar corresponds to 50% of the GTPgamma S-induced signal. (A-D) Fluorescence signals in the absence and presence of 2.5, 5.0, and 10.0 µM suramin, respectively. Solid lines are numerical solutions of rate equations (Eqs. 2 and 3) using ku = 0.14 µM-1s-1 and kh of 0.031 s-1 for all traces, whereas kc was reduced by factors of 0.43, 0.3, and 0.12 relative to its value of 0.7 µM-1s-1 in the absence of suramin. Additional thin lines in traces C and D are results from simulations in which kc and kh were fixed (at 0.7 µM-1s-1 and 0.031 s-1, respectively) at both suramin concentrations, whereas ku was 0.06 µM-1s-1 and 0.026 µM-1s-1 at 5 and 10 µM suramin, respectively. (E-G) Fluorescence changes induced by injection of GTP (2.5 µM) followed by GTPgamma S (6 µM) in the presence of heparin (7.5, 15.0, and 30.0 mg/L, respectively) measured in parallel with traces B-D in reaction mixtures made from identical stocks.

Fluorescence energy transfer from Gtalpha to suramin

The reduction of both basal Gt fluorescence and the GTPgamma S-induced fluorescence increase indicates that suramin binds to Gtalpha , thereby quenching its tryptophan fluorescence. The nucleotide-dependent fluorescence change of Trp207 was more affected than basal fluorescence. For example, basal fluorescence at 24 µM suramin was reduced by 50%, whereas the GTPgamma S-induced fluorescence change was reduced by 70% (Fig. 1, A and D). Quenching of Gtalpha fluorescence was further analyzed by fluorescence emission spectroscopy. When excited at 295 nm, Gtalpha fluorescence is maximal at 343 nm. With increasing suramin concentration, fluorescence at this wavelength decreased while emission from suramin above 400 nm increased (Fig. 3 A). At low suramin concentrations and 240 nM Gtalpha , appearance of suramin fluorescence was barely visible, whereas an isosbestic point formed at 377 nm at suramin concentrations above 0.5 µM. The spectra indicate that Gtalpha and suramin form a donor-acceptor pair undergoing FRET with spectral features almost identical with those described for other suramin-binding proteins (Mély et al., 1997; Zhang et al., 1998). At 480 nM Gtalpha , formation of an isosbestic point at 416 nm for suramin concentrations below 0.5 µM was reproducibly observed (Fig. 3 B). The decrease of Gtalpha fluorescence between 10 and 53 µM suramin and the concomitant increase of suramin fluorescence above 400 nm suggest that suramin binds to Gtalpha with a Kd > 10 µM. However, the insets in Fig. 3 show that the fraction of free Gtalpha (Eq. 4) was barely changing above 5 µM suramin when corrected for absorption of excitation and emission light by suramin (see Materials and Methods). The corrected data reveal that suramin binds to Gtalpha with a Kd of ~0.5 µM, typical of suramin binding to other G-proteins (Freissmuth et al., 1996). The fluorescence increase above 400 nm observed between 10 and 53 µM suramin was thus due to free suramin, and the decrease of tryptophan emission was caused by absorption of excitation light by suramin. This was expected as the amount of suramin exceeded that of Gtalpha by a factor of 40-200, implying preponderance of free suramin. Likewise, the upshift of the apparent isosbestic point at [suramin] > 0.5 µM from 377 nm to 390 nm at 240 and 480 nM Gtalpha , respectively, is entirely consistent with stronger tryptophan emission bands in Fig. 3 B versus A superimposed with directly excited fluorescence from free suramin.



View larger version (35K):
[in this window]
[in a new window]
 
FIGURE 3   Förster resonance energy transfer from Gtalpha to suramin. Solutions of purified Gtalpha (10 mM Tris, pH 7.2, 100 mM NaCl, 2 mM MgCl2, 1 mM DTT, 5 µM GDP) were excited at 295 nm and emission measured from 315 to 450 nm. (A and B) Gtalpha concentration was 240 and 480 nM, respectively. Suramin concentrations (from top to bottom) were 0.0, 0.25, 0.5, 0.74, 0.99, 1.23, 3.70, 6.14, 11.00, 20.58, 29.98, and 52.69 µM. Insets show the saturation of fluorescence quenching corrected for inner filtering by suramin (Materials and Methods) and for dilution (<13%) upon consecutive addition of aliquots from suramin stock solutions. Experiments were carried out at 27°C.

Influence of suramin on the structure of rhodopsin, MII, and MIIGt and on membrane anchoring of Gt

In addition to binding to Gtalpha , reduced Gt activation may be caused by suramin shifting the MI/MII equilibrium toward the inactive MI species. However, UV-visible absorption changes did not show an absorption increase in the 460-480-nm range (MI) at the expense of decreased 380-nm absorption (MII, not shown). We have addressed more subtle effects of suramin on the conformation of rhodopsin, MII, and MIIGt by ATR-FTIR spectroscopy. Light-induced conformational changes in rhodopsin are accompanied by characteristic shifts in the frequencies of vibrational modes of the structurally affected parts of the protein backbone, amino acid side chains, and the retinal chromophore as reviewed in Siebert (1995). Consequently, light-induced FTIR difference spectra allow the detection of perturbations of the normal structural changes during MII formation. In contrast to transmissive FTIR spectroscopy, the ATR-FTIR technique applied here monitors absorption changes of disk membranes adsorbed on an internal reflection element (IRE) in the presence of a bulk aqueous phase. In addition to structural changes, shifts in the binding equilibrium between Gt or suramin in the aqueous phase and in disk membranes give rise to IR-absorption changes as the amount of absorbing species in the evanescent field of the IRE (extending ~1 µm from its surface) is affected. IR absorption changes during MII formation at pH 5 are shown in Fig. 4 (negative bands are caused by the dark state, and positive bands correspond to absorption by MII). Except for a small additional positive band at 1040 cm-1, typical of suramin (Fig. 4 E), no alterations were observed in the difference spectrum recorded at 50 µM suramin (Fig. 4 B) versus normal MII formation (Fig. 4 A), although GTP-induced fluorescence signals were completely abolished at this concentration. At 500 µM suramin (Fig. 4 C), the light-induced absorption increase at 1040 cm-1 was larger, and additional alterations occurred in the amide I and II spectral range. These were identified by subtracting the normal MII difference spectrum from that measured in the presence of 500 µM suramin, resulting in the spectrum shown in Fig. 4 D. The flat baseline obtained between 1700 and 1800 cm-1 demonstrates that the C==O stretching vibrations of Asp83 (1767(-)/1747(+)), Glu113 (1711(+)), and Glu122 (1727(-)/1747(+)) (Fahmy et al., 1993; Rath et al., 1993; Jäger et al., 1994) were not altered. This confirms that the reduction of Gt activation cannot be attributed to a stabilizing effect of suramin on the MI state. A shift in the MI/MII equilibrium would have led to residual bands between 1700 and 1800 cm-1 (Fahmy, 1998) caused by protonated Glu122 and by protonation of Glu113 in MII. The absorption at 1040 cm-1 and the bands between 1400 and 1000 cm-1 correspond well with absorption by free suramin (Fig. 4 E) and indicate binding of suramin to photoactivated disk membranes. The alterations at 1650 and 1545 cm-1 may indicate an effect on the structure of dark rhodopsin at 500 µM suramin (i.e., in excess of serum concentrations of suramin in patients (Chaudhry et al., 1996)); however, the band at 1643 cm-1, typical of the Gt activating conformation of MII (Fahmy et al., 1994; Zvyaga et al., 1996), was not affected. In conclusion, the FTIR difference spectra argue against structural perturbations of rhodopsin or MII by suramin in the low micromolar range.



View larger version (30K):
[in this window]
[in a new window]
 
FIGURE 4   Light-induced ATR-FTIR spectra of rhodopsin. (A-C) Absorption changes typical of MII formation in the absence of suramin and at 50 and 500 µM suramin, respectively. Photoproduct bands show upwards, and absorption bands of the dark state are negative. Experiments were carried out at 10°C in buffer (10 mM sodium phosphate, pH 5, 100 mM NaCl) with disk membranes adsorbed on an IRE made of ZnSe. (D) Suramin-induced spectral changes in the MII difference spectra obtained by subtraction of trace A from trace C. (E) Infrared absorption of 60 mM suramin in H2O, measured by ATR-FTIR.

To study the influence of suramin on the structure of MIIGt, Gt was added to disk membranes in the dark. Binding of Gt is accompanied by characteristic absorption increases in the amide I (1610-1700 cm-1) and II (1510-1580 cm-1) frequency range (Fig. 5 A) as Gt accumulates in the evanescent field of the IRE. The functionality of MII Gt interactions under the conditions of the ATR-FTIR experiment has been demonstrated (Fahmy, 1998). After illumination, suramin was added by dialysis and ensuing absorption changes were recorded. Appearance of the drug in the evanescent field was evidenced by the sharp absorption increase at 1040 cm-1 (Fig. 5 B). In the amide I and II frequency range, slight absorption increases were observed as well and may have been caused by the amide groups in suramin or additional binding of Gt. More importantly, no negative bands occurred. Such bands are expected when suramin caused denaturation of MIIGt, thereby shifting vibrational frequencies of structurally affected peptide bonds. If suramin causes conformational changes in MIIGt at all, they must be smaller than those accompanying the light-dependent formation of MII or MIIGt, as these would clearly be visible as sharp superimposed difference bands of 1-3 mAU in the amide I/II range (Fahmy, 1998). Likewise, suramin does not dissociate MIIGt. As shown in Fig. 5 C, dissociation of MIIGt upon addition of nucleotide is not prevented either. GTPgamma S was added to the dialysis compartment in a higher concentrated sodium phosphate buffer, providing a monitor of the buffer exchange by the absorption increase of inorganic phosphate at 1077 and 988 cm-1. The loss of amide absorption of Gt coincided with the onset of absorption by inorganic phosphate, indicating that Gt dissociated from disk membranes with the arrival of the GTPgamma S-containing buffer in the evanescent field. The ATR-FTIR results suggest that the reduction of the apparent rate of Gtalpha (GTP) formation as determined by the Gt activation assay is caused neither by a shift in MI/MII equilibrium nor by altered structures of MII/MIIGt, nor by occupation of the GTP-binding site by suramin.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 5   ATR-FTIR spectra induced by suramin and GTPgamma S in Gt-loaded disk membranes in the light. (A) Binding of Gt (10 mM sodium phosphate, pH 7.2, 150 mM NaCl, 2 mM MgCl2, 1 mM DTT) in the dark to disk membranes. (B) Spectral changes accompanying dialysis of 30 µM suramin into the sample compartment after illumination (30 s with 150-W slide projector through GG495 Schott filter). (C) Spectral changes evoked by dialysis over 2, 5, and 15 min of 500 µM GTPgamma S and 20 mM sodium phosphate into the sample compartment. Spectral changes were calculated with respect to reference spectra recorded immediately before buffer exchange in the dialysis compartment. Experiments were carried out at 17°C.

To test the influence of suramin on steps before MIIGt formation, Gt was allowed to bind to disk membranes in the dark (Fig. 6 A) and suramin was added without prior photoactivation. With the arrival of suramin in the evanescent field (1040 cm-1 absorption increase) amide I and II absorption of Gt decreased. This demonstrates that suramin promoted dissociation of Gt from disk membranes. At 20 µM and 100 µM suramin, ~60% and 85% of Gt absorption was lost from the membranes, respectively. In a control experiment in which suramin was replaced by 3-kDa heparin no loss of absorption by Gt was observed (Fig. 6, D and E). In summary, the ATR-FTIR data indicate that suramin exerts its effect on signaling by rhodopsin through a loss of membrane affinity of Gt rather than by affecting the structure of rhodopsin, MII, MIIGt, or occupation of the GTP-binding site of Gt.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 6   ATR-FTIR spectral changes during association of Gt with disk membranes in the dark followed by suramin-induced dissociation. (A) Absorption increase after binding of Gt to disk membranes in the dark. (B) and (C) Absorption decrease induced by dissociation of Gt from membranes upon dialysis of 20 and 100 µM suramin, respectively, into the sample compartment. (D) Binding of Gt to disk membranes in an independent experiment. (E) Absorption changes during subsequent dialysis of 3-kDA heparin (100 µM) into the sample compartment. Experimental conditions as given in Fig. 5.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

The influence of suramin on coupling of Gt to rhodopsin

We have demonstrated that pharmacologically relevant concentrations of suramin affect activation of Gt by bovine rhodopsin. This has made possible an analysis of the mechanism by which suramin acts on G-protein signaling in a well characterized in vitro model system. Kinetic analyses of Gt activation demonstrate that suramin affects coupling of Gt to MII but alters neither the rate of nucleotide uptake nor GTP hydrolysis. Likewise, neither the MI/MII equilibrium nor the structure of rhodopsin and MIIGt is altered by suramin at concentrations that abolish Gt activation. Instead, the rate of association of Gt with MII is reduced.

MIIGt formation exhibits a fast component attributable to efficient collisions between MII and membrane-bound Gt and a slow component for the transition of Gt from a free to a disk-membrane-bound form (Schleicher and Hofmann, 1987). As membrane association is the rate-limiting step, the influence of suramin can be explained by inhibition of Gt binding to photoactivated disk membranes. The molecular processes underlying this transition may be very similar to or identical with those during association of Gt with membranes in the dark. Thus, suramin-induced dissociation of Gt from disk membranes in the dark, evidenced by ATR-FTIR, may be directly related to the mechanism by which MIIGt formation is impaired under conditions of multiple activation cycles. Because membrane anchoring of Gt is mediated by Gtalpha (Seitz et al., 1999), it is likely that suramin perturbs the membrane attachment site on Gtalpha . Binding of suramin to Gtalpha is evidenced by FRET and is characterized by a Kd of ~0.5 µM. The evaluation of Gt activation rates is in general agreement with this Kd. Even in the realm of a simplified reaction model, including only GTP uptake and hydrolysis, half-maximal inhibition occurred at 6 µM suramin, whereas 3 µM would be expected from the estimated Kd of 0.5 µM (conditions of the experiment shown in Fig. 1). In a more realistic three-step model, 50% reduction of the rate constant for MIIGt complex formation was observed at 2.5 µM suramin concentration. This agrees precisely with 50% saturation of suramin-binding sites with a Kd of ~0.5 µM (conditions of the experiment shown in Fig. 2) and strongly suggests that suramin binds in a 1:1 stoichiometry to Gtalpha as reported for binding to Gsalpha (Hohenegger et al., 1998). Half-maximal dissociation of Gt from disk membranes measured by ATR-FTIR spectroscopy occurred at higher suramin concentration (10-20 µM). Taking into account the different experimental conditions, the concentrations for half-maximal effects of suramin in both assays appear to be very similar. Therefore, our data suggest that 1) occupation of a single suramin-binding site on Gtalpha with Kd of ~0.5 µM is the predominant cause for the inhibition of rhodopsin-catalyzed Gt activation, and 2) the rate of complex formation between suramin-bound Gt and MII is specifically impaired by a reduced affinity of suramin-bound Gtalpha for photoreceptor membranes.

Reduction of membrane affinity of Gtalpha by suramin may involve electrostatic repulsion of suramin-bound Gtalpha (carrying six negative extra charges) from disk membranes and/or interference with the exposure of the N-terminal acyl chains. Results from SDS-PAGE of supernatants of Gt-containing solutions (3 µM) equilibrated in the dark with disk membranes agree with a reduced membrane affinity of Gt in the presence of suramin (data not shown). The same holds for binding of Gt to electrically neutral phosphatidylcholine vesicles, rendering likely a specific effect on lipid anchoring. The topology of the suramin-binding site on Gtalpha needs further investigation, but one of the two chromophoric 1,3,6-naphthalenetrisulfonate (NTS) moieties may bind near Trp207. This is suggested by the suramin-dependent reduction of nucleotide-induced fluorescence changes of Gtalpha known to arise from Trp207. Although binding of suramin to nucleotide-binding sites has been described for other proteins (van Rhee et al., 1994; Khaled et al., 1995), the different elution properties of nucleotides versus suramin (Figs. 5 and 6) and the unaltered rate constant for nucleotide uptake consistently disfavor binding to the nucleotide-binding site of Gt. Electrostatic interactions between NTS and positively charged amino acids have been inferred from the solution structure of NTS-bound acidic fibroblast growth factor (Lozano et al., 1998) and may be crucial for binding of NTS to Gt as well. Preliminary docking simulations using the program FlexX provided by the Gesellschaft für Mathematische Datenanalyse (Bonn, Germany), also resulted in highest-scoring solutions for binding of NTS to Gtalpha (Protein Data Bank entry 1TAD) in positions within less than 3 Å from the positively charged guanidinium groups of Arg201 and Arg204 and 10-15 Å apart from Trp207. We suspect that the drug approaches the N-terminus of Gtalpha where it may interfere with membrane anchoring (Matsuda et al., 1994; Seitz et al., 1999) and may additionally affect electrostatically driven steps during receptor recognition (Fanelli et al., 1999).

Comparison with the action of suramin on other receptor G-protein tandems

Structural and functional properties are probably conserved among members of each class of GPCRs. Two modes of action of suramin on Gs-, Gi-, and Go-dependent signaling by class I (rhodopsin-like) GPCRs have been described. One mode is the reduction of basal nucleotide exchange at submicromolar to micromolar concentrations of suramin. We have shown here that suramin binds to Gtalpha in a 1:1 stoichiometry as reported for other G-proteins (Hohenegger et al., 1998) and with a Kd that falls in the same range as the EC50 for suppression of basal nucleotide exchange. However, Gt does not exhibit receptor-independent nucleotide exchange. Correspondingly, the rhodopsin Gt model system was not expected to respond to this particular mode of suramin action. Another mode of suramin action is uncoupling from the receptor (Beindl et al., 1996). We have demonstrated that inhibition of rhodopsin-dependent Gt activation does indeed occur. It has been shown for Gsalpha that suramin binds not only to epitopes involved in receptor recognition but also overlaps with effector binding sites (Freissmuth et al., 1996). Trp207 in Gtalpha is near switch II of Gtalpha and thus close to regions that bind to the effector (Berlot and Bourne, 1992; Rarick et al., 1992). Binding of suramin to that region would also be consistent with the preferential quenching of fluorescence from Trp207. Finally, binding of suramin to Gialpha /Gsalpha has been shown to cause dissociation of the ternary complex with agonist-bound receptors (Beindl et al., 1996). Because the agonist of rhodopsin, all-trans retinal, is covalently bound, an analogous action of suramin was not expected in this system, and dissociation of MIIGt was not observed. This parallels the quasi-competitive behavior of suramin with respect to agonist as increasing receptor occupancy could reverse the destabilizing effect of suramin on the ternary complex of ligand-activated receptors.

The action of suramin on signaling by other G-protein alpha -subunits appears to be paralleled by its action on Gt when the unique features of this system are taken into account. Our data further suggest that inhibition of receptor-catalyzed G-protein activation may operate through a reduced membrane affinity of suramin-bound G-protein alpha -subunits. Binding to membranes is primarily mediated by Galpha -palmitoylation and to a less extent by N-terminal myristoylation (as reviewed in Wedegaertner et al., 1995; Milligan and Grassie, 1997). Gt is not palmitoylated and may be particularly sensitive to destabilization of membrane anchoring via a single N-terminal acylation. However, G-protein palmitoylation is a dynamic process. For example, palmitate turnover on Gsalpha in S49 cells has been shown to become accelerated upon beta -adrenergic receptor activation (Wedegaertner and Bourne, 1994). Therefore, the acylation state and, correspondingly, the membrane affinity of other Galpha -subunits may transiently correspond with that of Gt.


    CONCLUSIONS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

Rhodopsin Gt interactions may constitute a versatile in vitro model system to elucidate the action of suramin-related drugs on G-protein-dependent signaling. Furthermore, our results hint at a possible adverse effect on scotopic vision in patients receiving suramin treatment. Constant monitoring of dosage in these patients is important because of toxic effects of suramin. A putative impairment of rhodopsin-mediated dim light vision by suramin needs further investigation as it may correlate with other adverse effects that need to be controlled in clinical studies.

We thank Prof. T. P. Sakmar, in whose lab G.K.A. is a post-doctoral associate. We are also grateful to Prof. K. Vogt who generously provided the laboratory for K.F. at the Institut fuer Biologie I at University Freiburg. Furthermore, introduction to the program FlexX by Dr. G. Metz and excellent technical assistance from B. Mayer is gratefully acknowledged.

    ACKNOWLEDGMENTS

This research was supported by Deutsche Forschungsgemeinschaft grant FA 248/4-1 to K.F.

    FOOTNOTES

Address reprint requests to Dr. Karim Fahmy, Institut für Molekulare Medizin und Zellforschung, Universität Freiburg, Albertstrasse 23, D-79104 Freiburg, Germany. Tel.: 49-761-203-5380; Fax: 49-761-203-2921; E-mail: fahmy{at}uni-freiburg.de.

Submitted July 26, 2001, and accepted for publication October 1, 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES